iData Research Logo

A Trusted Source of Intelligent Data

  • Solutions
    • Subscription Model *NEW*
    • Healthcare Market Reports
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Medical Market Surveys
    • Total Sales Solution
    • Custom Consulting
    • iData Pharma
    • iData Online
  • Reports
  • Platforms
  • News
    • MedTech Future
    • CardioFuture
    • DentalFuture
    • OrthoFuture
    • COVID-19
    • Press Releases
  • About Us
    • About Us
    • Do it Right
    • Research Methodology
    • Careers
    • Testimonials
    • FAQs
  • Contact Us
  • Serach
  • Login
Sign In
  • Home
  • Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study
Search for:

Category: Cardiology

Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study

Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study

iData Research 17/01/2018
Register to receive a free Interventional Cardiology Devices Market Report Suite for US 2018-2024 synopsis and brochure The Christ Hospital, Lindner Research Center in Cincinnati, Ohio, enrolled the... Read More
Abbott, Boston Scientific Lead Japan Interventional Cardiology Device Market Due to New Expensive Technologically Advanced Devices

Abbott, Boston Scientific Lead Japan Interventional Cardiology Device Market Due to New Expensive Technologically Advanced Devices

iData Research 15/11/2017
The Japanese interventional cardiology market is projected to reach an estimated $1.61 billion by 2024 due to growth of the IVUS catheter and FFR guidewire markets.... Read More
Edwards Lifesciences, Medtronic Lead US Market for Transcatheter Heart Valve Replacement Devices Fueled by Growing Demand for Minimally Invasive Surgeries

Edwards Lifesciences, Medtronic Lead US Market for Transcatheter Heart Valve Replacement Devices Fueled by Growing Demand for Minimally Invasive Surgeries

iData Research 14/11/2017
Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves, this large potential patient population will help drive the transcatheter heart valve replacement market... Read More
Sutureless Tissue Heart Valves, Reinvigorating the Market

Sutureless Tissue Heart Valves, Reinvigorating the Market

iData Research 24/10/2017
Heart valve replacement procedures are a type of cardiac surgery. Generally, heart valve replacement is an open operation. However, recent advancements in technology has allowed for minimally invasive... Read More
Firmware Update to Address Cybersecurity Vulnerabilities Identified in Abbott's (formerly St. Jude Medical's) Implantable Cardiac Pacemakers: FDA Safety Communication

Firmware Update to Address Cybersecurity Vulnerabilities Identified in Abbott’s (formerly St. Jude Medical’s) Implantable Cardiac Pacemakers: FDA Safety Communication

iData Research 01/09/2017
This access could be used to modify programming commands to the implanted pacemaker, which could result in patient harm from rapid battery depletion or administration of inappropriate pacing.... Read More
Medtronic Expands Cardiac Surgery Device Portfolio with FDA and CE Mark Approvals: Avalus Surgical Aortic Valve, CoreValve Evolut PRO Transcatheter Valve

Medtronic Expands Cardiac Surgery Device Portfolio with FDA and CE Mark Approvals: Avalus Surgical Aortic Valve, CoreValve Evolut PRO Transcatheter Valve

iData Research 14/08/2017
Introduction of New Pericardial Aortic Heart Valve in the U.S. and Europe Reinforces Company's Commitment to Comprehensive Solutions to Heart Valve Disease... Read More
Medtronic First to Receive Health Canada Licence for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Medtronic First to Receive Health Canada Licence for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

iData Research 03/08/2017
Amplia MRI™ and Compia MRI™ CRT-Ds, Licenced for Patients with Heart Failure, Can Safely Undergo Full Body MRI Scans... Read More
Philips to Acquire The Spectranetics Corporation to Accelerate Expansion in Image-Guided Therapy Devices to Treat Cardiac and Peripheral Vascular Disease

Philips to Acquire The Spectranetics Corporation to Accelerate Expansion in Image-Guided Therapy Devices to Treat Cardiac and Peripheral Vascular Disease

iData Research 19/07/2017
Royal Philips and The Spectranetics Corporation recently announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire... Read More
  • 18 of 18
  • « Previous
  • 1
  • …
  • 16
  • 17
  • 18

    Want more information about the market report mentioned in this article?

    Free Sample Report
    Subscribe to iData News

    We publish medical, dental, and pharmaceutical news and market insights from our analysts every day. Sign up for your free subscription here:

    Subscribe
  • [save_as_pdf_pdfcrowd]
+

Free Sample Report

    [create_popup_free_sample_report_rorm_v6]

    Subscribe to our Newsletter
    Subscribe

    OUR ADDRESS

    • 602-7300 Edmonds St, Kings Crossing, Burnaby, BC V3N 0G8, Canada
    • 8 The Green #21910, Dover, DE, 19901, United States
    • +1 (604) 266-6933
    • info@idataresearch.net

    SOLUTIONS

    • Report
    • Custom Consulting
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Surveys
    • Total Sales Solution
    • Pharmaceuticals
    • iDataOnline

    NEWS

    • Blog
    • MedTech Future
    • Cardio Future
    • Dental Future
    • Ortho Future
    • Subscribe

    ABOUT US

    • About iData
    • Our Methodology
    • Testimonials
    • FAQ
    • Careers

    OTHER

    • Terms of Use
    • Privacy Policy
    • Sitemap

    Copyright © 2005 - 2026 iData Research. All Rights Reserved